Christopher Degnan
Overview
Christopher Degnan received an average of $1M in total compensation, including $349K in salary, at Galera Therapeutics from 2019 to 2023.
Source: SEC filings on January 24, 2025, April 27, 2023, April 28, 2022, and April 27, 2020.
Related executives
We found three more executives who work or worked at Galera Therapeutics.
News
Galera Therapeutics CEO J Sorensen's 2023 pay slips 8% to $1.3M
11 hours ago
Galera Therapeutics CEO J Sorensen's 2022 pay falls 46% to $1.4M
April 27, 2023
Galera Therapeutics CEO J Sorensen's 2021 pay slips 14% to $2.5M
April 28, 2022
Galera Therapeutics CEO J Sorensen's 2019 pay jumps 373% to $2.5M
April 27, 2020